Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (412)

  • Sarmiento, E; Montanchez, J; Ezzahouri, I; Cifrian, J; Ortiz-Bautista, C; Laporta, R; Bravo, C; Salcedo, M; Rodriguez-Ferrero, ML; Gonzalez-Costello, J; Segovia, J; De Pablos, A; Mora, V; Ussetti, P; Lopez, S; Sabe, N; Gomez-Bueno, M; Sousa, I; Navas, P; Diez-Villanueva, P; Aguilar, M; Fernandez-Yunquera, A; Anaya, F; Muñoz, P; Valerio, M; Mur, A; Alarcon, A; Limay, K; Lopez-Hoyos, M; Lopez, F; Vionnet, A; Serrano, M; Carbone, J.

    Evaluation of IVIG for Prevention of Infections Occurring On-study and Treatment of Infection of Solid Organ Recipients With Secondary Antibody Deficiency: A Phase 2 Randomized Clinical Trial

    Transplantation Direct. 2026; 12(4): [doi:10.1097/TXD.0000000000001928]

  • García-Díaz, HC; Gómez-Alonso, J; Rabuñal-Alvarez, MT; Ochagavía, M; Revuelta-Herrero, JL; González-Gómez, A; Riestra, AC; Oliver-Noguera, A; García, MM; Farriols, A; Macarulla, T; Carreras, MJ; Larrosa-Garcia, M.

    Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals

    JOURNAL OF CHEMOTHERAPY. 2026; : [doi:10.1080/1120009X.2026.2639277]

  • Torroba-Sanz, B; de Lorenzo-Pinto, A; Gimenez-Manzorro, A; Redondo-Galan, C; Gomez-Costas, D; Benedí, J; Herranz-Alonso, A; Sanjurjo-Saez, M.

    PharmaCenter: Impact of post-discharge pharmaceutical carea consultation on medication-related problems in the emergenc department: A comprehensive analysis

    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. 2026; 22(2): 311-316 [doi:10.1016/j.sapharm.2025.10.010]

  • Pizarro-Gómez, C; Collado-Borrell, R; Escudero-Vilaplana, V; Massarrah, T; Revuelta-Herrero, JL; Calles, A; Alvarez, R; Villanueva-Bueno, C; Mur-Mur, A; Sánchez-Fresneda, MN; Herranz, A; Benedí-González, J; Martín, M; Sanjurjo, M.

    Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2026; : [doi:10.1177/10781552251409387]

  • Tato-Moreno, P; Olleros, CL; Martín, HB; Guerrero, MB; Mensa-Vilaro, A; Durán-García, ME; Sánchez-Mateos, P; García-Martínez, E.

    Exploring targeted therapy in retinal vasculopathy with cerebral leukoencephalopathy: a case report and review of literature

    Frontiers in Immunology. 2026; 16: 1707532-1707532 [doi:10.3389/fimmu.2025.1707532]

  • Galnares, MR; Morillo-Verdugo, R; Robustillo-Cortes, MD; Vélez-Diaz-Pallarés, M; Albir, MJC; Vega, BP; López, LL; Ventura, LM; Villanueva, MF; Atorrasagasti, OM; Gutiérrez, E.

    Impact of a CMO-Based Pharmaceutical Care Model on 3-HIT Criteria in Older People Living with HIV: The DIS3HIT Project

    Patient Preference and Adherence. 2026; 20: 1-12 [doi:10.2147/PPA.S569460]

  • Ramos, JR; Peláez, MG; Clemente, YC; Requejo, CC; Alcón, EV; Mora, JRR; Blanch, CT; Palomares, AG; Costas, DG.

    Adverse events associated with the use of flumazenil in the Emergency Department

    MEDICINA CLINICA. 2026; 166(1): [doi:10.1016/j.medcli.2025.107312]

  • Salgado-Cámara, P; De la Casa-Fages, B; Sánchez-Soblechero, A; Sierra, OM; Martín-Barbero, ML; Grandas, F.

    Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs

    NEUROLOGIA. 2026; 41(1): [doi:10.1016/j.nrl.2023.11.011]

  • Taladriz-Sender, I; Salvador-Martin, S; Zapata-Cobo, P; López-Fernández, LA; Sanjurjo-Sáez, M; Garcia-González, X.

    Update on pharmacogenetics in pediatrics

    ANALES DE PEDIATRIA. 2026; 104(1): Nº de citas: 1 [doi:10.1016/j.anpedi.2025.503936]

  • León-Tarife, P; Arnalich-Montiel, F; Mingo-Botin, D; de Maria, FD; Stokking, M; Saenz-Madrazo, N; Etxebarria-Ecenarro, J; Arriola-Villalobos, P; de los Bueis, AB; González-Diaz, I.

    Self-supervised learning and hybrid deep models for predicting the progression of Fuchs' endothelial corneal dystrophy after cataract surgery

    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE. 2026; 273: 109100-109100 [doi:10.1016/j.cmpb.2025.109100]

  • Climente-Martí, M; García-González, X; Torres-Bondia, FI; Lozano, J; Gómez-Navarro, V.

    Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting

    Journal of Medical Economics. 2025; 28(1): 1857-1868 [doi:10.1080/13696998.2025.2575456]

  • Ripa, C; Olariaga, O; Vallinas, S; Sirvent, M; Prado, E; Romero, R; Perez, L; Terroba, P; Hernández, S; Chica, A; Gandara, MJ; Bourgon, L; Ochagavia, M; Tamayo, R; Leunda, L.

    OncoNutridos study: Prevalence of disease-related malnutrition according to GLIM criteria in cancer patients in oncohaematology day hospitals

    Clinical Nutrition ESPEN. 2025; 70: 666-675 [doi:10.1016/j.clnesp.2025.11.008]

  • Somoza-Fernandez, B; de Lorenzo-Pinto, A; Escudero-Vilaplana, V; Manrique-Rodriguez, S; Villanueva-Bueno, C; Martin-Barbero, ML; Redondo-Galan, C; Calatayud-Garcia, J; Gonzalez-Ramallo, V; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Standardizing hospital pharmacy practice in home hospitalization: results from a multidisciplinary Delphi consensus in Spain

    Frontiers in Public Health. 2025; 13: [doi:10.3389/fpubh.2025.1707726]

  • Jiménez, RMR; Pinto, PH; Domínguez, MC; Bellmunt, A; Vidal-Vilar, N; Soto, MDF; Juste, AD.

    Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain

    Pharmacoeconomics-Open. 2025; 10(1): 209-213 [doi:10.1007/s41669-025-00616-9]

  • Roncero, C; Sánchez-García, A; Burguet, LC; Moreno, AF; Barbero, MLM; Aguilera-Serrano, C; Dorado, VO; Remacha, JG; Prieto, JR; Pérez-Esteve, C; Vila, MS; Solves, JJM.

    Relevant Criteria for Improving Quality of Schizophrenia Spectrum Disorders Treatment: A Delphi Study

    Healthcare. 2025; 13(22): [doi:10.3390/healthcare13222847]

  • Suárez-Casillas, P; Mejías-Trueba, M; Peñalva, G; Fontán-Díaz, F; Villanueva-Bueno, C; Herrera-Hidalgo, L; Varela-Rubio, E; Jiménez-Parrilla, F; Cisneros, JM; Gil-Navarro, MV; Guisado-Gil, AB.

    Antimicrobial Use Monitoring in Neonatal Population Using a Defined Daily Doses Method

    Neonatology. 2025; 123(1): 64-73 [doi:10.1159/000548869]

  • Cerezuelaa, MM; Morenob, FB; Ramosc, JR; Pintod, AD; Chivae, ED; Rubiof, MV; Gonzálezg, IA; Fernándezh, CB; Morali, LD; Lugeaj, AE; Garciak, MAA; Garcial, TB; Sacristánm, SC; Fernándezh, MA; Pérezn, SO; Tomáso, LPD.

    [Translated article] Development of the mobile application Guide to medication reconciliation in the critically ill patient

    FARMACIA HOSPITALARIA. 2025; 49(6): 367-372 [doi:10.1016/j.farma.2025.06.007]

  • Cerezuela, MM; Moreno, FB; Ramos, JR; Pinto, AD; Chiva, ED; Rubio, MV; González, IA; Fernández, CB; Moral, LD; Lugea, AE; Garcia, MAA; Garcia, TB; Sacristán, SC; Fernández, MA; Pérez, SO; Tomás, LPD.

    Development of the critically ill patient mobile application Guide to medication reconciliation in the critically ill patient

    FARMACIA HOSPITALARIA. 2025; 49(6): 367-372 [doi:10.1016/j.farma.2025.03.021]